Selig praises new supplement law, J.C. Romero awaits apology

Leave a comment

Senators McCain and Dorgan introduced some new legislation today that proposes to more closely regulate the supplement industry in the wake of reports that many products contain designer steroids and other such nasties which aren’t disclosed to the public.  Bud Selig just released a statement on it:

“On behalf of Major League Baseball, I would like to thank Senators
John McCain and Byron Dorgan for their efforts to broaden the Food and
Drug Administration’s regulatory authority over dietary supplements. We
fully support the proposed legislation designed to protect athletes and
consumers from dangerous, mislabeled and tainted over-the-counter
supplements. The continued leadership of Senators McCain and Dorgan has
made an impact on this important issue.”

That’s all good, but if Selig really believed that mislabled and tainted over-the-counter supplements were a problem, why didn’t he buy J.C. Romero’s defense? Romero, you’ll recall, was suspended 50 games for taking something he bought from a GNC store which both he and the MLBPA thought was OK, and contained no evidence that it had bad stuff in it on the label, but turned out to have a banned hormone in it. Baseball didn’t think that got him off the hook and he served his suspension because, according to Major League Baseball, he was “negligent.”

If baseball really thinks guys like Romero were “negligent” then you’d think they’d issue a statement saying that the new law is unnecessary.

UPDATE:  Just had a conversation with someone at Major League Baseball. Their view — which makes a good deal of sense, I’ll admit — is that the drug policy sort of has to take the kind of zero-tolerance approach that was taken in the Romero case, or else enforcement actions are going to be prone to a bunch of “I didn’t know what I was taking” defenses, rendering the policy largely ineffective. Ultimately, the issue is whether a player — despite his intentions — competed in a game with a banned substance in his system. I can see that. Baseball’s drug policy, while having multiple purposes, should probably have “making sure athletes are competing on a level playing field” as its top priority.

But one question I do have is that, if that’s the case, what’s the point of even having an appeals and arbitration process like the one Romero went through in the first place? Why not just a test-positive-no-appeal kind of system? Or at the most an appeals process that only scrutinizes the science of it all, such as whether the test itself was wrongly administered or whether the samples were tainted or what have you?

The Padres are aggressively shopping Yangervis Solarte

PHOENIX, AZ - OCTOBER 01:  Third baseman Yangervis Solarte #26 of the San Diego Padres fields a ground ball against the Arizona Diamondbacks during the sixth inning of a MLB game at Chase Field on October 1, 2016 in Phoenix, Arizona.  (Photo by Ralph Freso/Getty Images)
Ralph Freso/Getty Images
Leave a comment

In a column published on Sunday, Ken Rosenthal of FOX Sports says the Padres are “aggressively shopping” third baseman Yangervis Solarte. The 29-year-old is entering his first of three years of arbitration eligibility and is projected to earn $2.7 million next season.

This past season, Solarte hit a solid .286/.341/.467 with 15 home runs and 71 RBI in 443 plate appearances. It’s quite impressive factoring in that he plays in the pitcher-friendly Petco Park.

Given that Solarte is team-controlled for three more years and he offers lots of versatility with previous experience playing first and second base as well as corner outfield, the Padres should receive a fair amount of interest.

Yankees sign Matt Holliday to a one-year, $13 million deal

ST. LOUIS, MO - JULY 20: Matt Holliday #7 of the St. Louis Cardinal hits a solo home run during the second inning against the San Diego Padres of game one of a doubleheader at Busch Stadium on July 20, 2016 in St. Louis, Missouri. (Photo by Scott Kane/Getty Images)
Scott Kane/Getty Images
6 Comments

Update (6:52 PM EST): The deal is expected to be one year for $13 million, per Jon Heyman of FanRag Sports. Ken Rosenthal of FOX Sports confirms the report.

*

The Yankees are close to signing veteran free agent Matt Holliday, WFAN’s Sweeny Murti reports.

Holliday, who turns 37 years old next month, was limited to 110 games in 2016 with the Cardinals due to a fractured left thumb suffered in the second half. He finished the season hitting .246/.322/.461 with 20 home runs and 62 RBI in 426 plate appearances.

Holliday is likely looking at spending the majority of his time in the DH role. Alex Rodriguez, Carlos Beltran, and Brian McCann handled the DH role for a majority of the time last season but all three have moved on — Rodriguez was released in the second half, Beltran just signed with the Astros, and McCann was traded to the Astros last month.